Cardiovascular disease, and in particular ischemic heart disease (IHD), is a major cause of
morbidity and mortality in the very elderly (> 80 years) worldwide. These patients represent a …

Background Despite several randomized controlled trials and meta-analyses, the ideal
anticoagulant for patients undergoing primary percutaneous coronary intervention (PCI) …

Mesenchymal stem cells (MSCs) are currently under investigation as tools to preserve
cardiac structure and function following acute myocardial infarction (AMI). However …

Context Patients undergoing elective percutaneous coronary intervention (PCI) are
generally observed overnight in the hospital. The association between same-day discharge …

Objectives: This study sought to assess the safety of same-day discharge in patients
undergoing percutaneous coronary intervention (PCI). Background: The safety of same-day …

Background: There has been a decline in hospital length of stay (LOS) after primary
percutaneous coronary intervention (PPCI) for ST-segment elevation myocardial infarction …

Objectives: The authors sought to describe the association between post-procedural
bleeding and long-term recurrent bleeding, major adverse cardiac events (MACE), and …

Objective To examine whether prospective bleeding risk estimates for patients undergoing
percutaneous coronary intervention could improve the use of bleeding avoidance strategies …

Percutaneous coronary intervention for acute coronary syndrome or non–ST-elevation
myocardial infarction requires the use of potent oral and intravenous anti-platelet and …

Known to be biocompatible and hemocompatible, polyethylene glycol (PEG) has been
widely used as anti-fouling coating of biomaterials. Nanoparticles coated with functionalized …